Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population
This makes it much faster and more reliable especially for people who cannot absorb B12 properly through food or supplements
The key is having your thigh relaxed, not tensed
(2) F M Ng, W J Jiang, R Gianello, S Pitt, and P Roupas (2000)
The entire process, including a brief medical assessment, takes about 30 to 60 minutes